| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $186K | +27.4% |
| SG&A Expense | $1.2M | -56.2% |
| Operating Income | -$1.4M | +49.3% |
| Interest Expense | $1.7M | +348.4% |
| Income Tax | $0 | — |
| Net Income | -$1.7M | +31.7% |
| EPS (Basic) | -$0.10 | +54.5% |
| EPS (Diluted) | -$0.10 | +54.5% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64K | -64.4% |
| Total Assets | $125K | -40.0% |
| Current Liabilities | $4.8M | +20.3% |
| Total Liabilities | $4.8M | +15.5% |
| Stockholders' Equity | -$4.7M | -18.5% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$903K | -32.4% |
| Financing Cash Flow | $787K | -8.8% |